Facebook
Twitter
Telegram
Fehler meldenMarinus Pharmaceuticals Bilanz 2011-2024 | MRNS
Bilanz Jährlich Marinus Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-44.8 M | -165 M | - | -138 M | -90.5 M | -67.7 M | -33.5 M | -20.9 M | -44.3 M | -42.7 M | -10 M | -5.96 M | - |
Langfristige Schulden |
75 M | 75 M | - | - | - | - | - | 1.74 M | 5.25 M | 7 M | - | - | - |
Langfristiger Schuldenstrom |
774 K | 637 K | - | - | - | - | - | - | 2.13 M | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 2.53 M | 3.04 M | - | 120 K | 1.88 M | 5.31 M | 7.02 M | - | - | - |
Kurzfristige Verbindlichkeiten |
40.6 M | 25 M | 40.6 M | 10.7 M | 8.03 M | 6.91 M | 2.54 M | 8.08 M | 7.44 M | 2.04 M | - | - | - |
Gesamtverbindlichkeiten |
154 M | 144 M | 83.4 M | 13.3 M | 11.1 M | 6.91 M | 2.66 M | 9.97 M | 12.7 M | 9.06 M | 2.37 M | 4.5 M | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-572 M | -431 M | -411 M | -312 M | -236 M | -181 M | -145 M | -126 M | -97.2 M | -72.3 M | -61.5 M | -56.2 M | - |
Vermögenswerte |
171 M | 260 M | 137 M | 150 M | 98.8 M | 75.2 M | 60.7 M | 31.4 M | 59.7 M | 50.2 M | 11.8 M | 8.68 M | - |
Zahlungsmittel |
121 M | 241 M | 123 M | 139 M | 90.9 M | 67.7 M | 33.5 M | 26.2 M | 51.7 M | 49.7 M | 10 M | - | - |
Buchwert |
16.8 M | 116 M | 53.5 M | 137 M | 87.8 M | 68.3 M | 58 M | 21.5 M | 46.9 M | 41.2 M | 9.46 M | 4.18 M | - |
Gesamtes Eigenkapital |
16.8 M | 116 M | 53.5 M | 137 M | 59.6 M | 68.3 M | 58 M | 21.5 M | 46.9 M | 41.2 M | -60.4 M | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Marinus Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
75 M | - | 75 M | 75 M | 75 M | - | 75 M | 75 M | 75 M | 45 M | 45 M | 15 M | 2.4 M | 2.53 M | 2.66 M | 2.8 M | 2.92 M | 3.04 M | 3.16 M | 3.18 M | 3.2 M | - | - | - | - | - | - | - | - | 5.25 M | - | - | - | 7.38 M | 7 M | 7 M | 7 M | 7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
154 M | 154 M | 146 M | 144 M | 142 M | 144 M | 103 M | 105 M | 100 M | 83.4 M | 80.4 M | 29.9 M | 18.5 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 6.91 M | 6.91 M | 6.91 M | 6.91 M | 2.66 M | 2.66 M | 2.66 M | 2.66 M | 9.97 M | 9.97 M | 9.97 M | 9.97 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 9.06 M | 9.06 M | 9.06 M | 9.06 M | 2.37 M | 2.37 M | 2.37 M | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-611 M | -572 M | -530 M | -497 M | -465 M | -431 M | -396 M | -469 M | -430 M | -411 M | -382 M | -363 M | -339 M | -312 M | -312 M | -312 M | -312 M | -236 M | -236 M | -236 M | -236 M | -181 M | -181 M | -181 M | -181 M | -145 M | -145 M | -145 M | -145 M | -126 M | -126 M | -126 M | -126 M | -97.2 M | -97.2 M | -97.2 M | -97.2 M | -72.3 M | -72.3 M | -72.3 M | -72.3 M | -61.5 M | -61.5 M | -61.5 M | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
137 M | 171 M | 201 M | 201 M | 227 M | 260 M | 185 M | 109 M | 141 M | 137 M | 159 M | 125 M | 134 M | 150 M | 150 M | 150 M | 150 M | 98.8 M | 98.8 M | 98.8 M | 98.8 M | 75.2 M | 75.2 M | 75.2 M | 75.2 M | 60.7 M | 60.7 M | 60.7 M | 60.7 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 59.6 M | 59.6 M | 59.6 M | 59.6 M | 50.2 M | 50.2 M | 50.2 M | 50.2 M | 11.8 M | 11.8 M | 11.8 M | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
104 M | 121 M | 140 M | 128 M | 147 M | 241 M | 168 M | 92.3 M | 126 M | 123 M | 145 M | 112 M | 123 M | 139 M | 139 M | 139 M | 139 M | 90.9 M | 90.9 M | 90.9 M | 90.9 M | 67.7 M | 67.7 M | 67.7 M | 67.7 M | 33.5 M | 33.5 M | 33.5 M | 33.5 M | 26.2 M | 26.2 M | 26.2 M | 26.2 M | 51.7 M | 51.7 M | 51.7 M | 51.7 M | 49.7 M | 49.7 M | 49.7 M | 49.7 M | 10 M | 10 M | 10 M | - | 8.63 M | - | - | - | - | - | - | - |
Buchwert |
-16.4 M | 16.8 M | 54.5 M | 57.3 M | 85.1 M | 116 M | 82 M | 4.8 M | 40.4 M | 53.5 M | 78.5 M | 95.1 M | 115 M | 137 M | 137 M | 137 M | 137 M | 87.8 M | 87.8 M | 87.8 M | 87.8 M | 68.3 M | 68.3 M | 68.3 M | 68.3 M | 58 M | 58 M | 58 M | 58 M | 21.5 M | 21.5 M | 21.5 M | 21.5 M | 46.9 M | 46.9 M | 46.9 M | 46.9 M | 41.2 M | 41.2 M | 41.2 M | 41.2 M | 9.46 M | 9.46 M | 9.46 M | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
-16.4 M | 16.8 M | 54.5 M | 57.3 M | 85.1 M | 116 M | 82 M | 4.8 M | 40.4 M | 53.5 M | 78.5 M | 95.1 M | 115 M | 137 M | 137 M | 137 M | 137 M | 59.6 M | 59.6 M | 59.6 M | 59.6 M | 68.3 M | 68.3 M | 68.3 M | 68.3 M | 58 M | 58 M | 58 M | 58 M | 21.5 M | 21.5 M | 21.5 M | 21.5 M | 46.9 M | 46.9 M | 46.9 M | 46.9 M | 41.2 M | 41.2 M | 41.2 M | 41.2 M | -60.4 M | -60.4 M | -60.4 M | - | -55.4 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung